Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DuPont de Nemours, Inc.DWDP · Entity 3297 | Special Counsellor · General Counsel-MatCo | August 27, 2018 | August 30, 2018 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DuPont de Nemours, Inc.
Report date August 27, 2018 · Filed August 30, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 306,848.7416 |
Ending reported balance
After 2018-08-27 transaction · row 2
2 source rows · reconciled sequenceRow 1 · 2018-08-27 · Exercise / conversion · Acquired 100,645 · Balance 407,493.7416 Row 2 · 2018-08-27 · Sale · Disposed 100,645 · Balance 306,848.7416 F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2: The price represents the weighted average sale price. All sales occurred at a range of $70.69 to $70.86. |
| Non-Qualified Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15 | Direct | 0 |
Reported balance
After 2018-08-27 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2018-08-27 · Exercise / conversion · Disposed 100,645 · Balance 0 F3: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F4: The options vested in three annual installments beginning on February 15, 2014. |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan | 1,115.079 |
Reported balance
Holding disclosure · report date 2018-08-27 · row 3
Holding and transaction disclosures are not merged.
1 source rowRow 3 · Balance 1,115.079 |
| Common StockSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 4,364.711 |
Reported balance
Holding disclosure · report date 2018-08-27 · row 4
Holding and transaction disclosures are not merged.
1 source rowRow 4 · Balance 4,364.711 |
Filing footnotes · ownership attribution and instrument terms
F1: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F2: The price represents the weighted average sale price. All sales occurred at a range of $70.69 to $70.86.
F3: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights.
F4: The options vested in three annual installments beginning on February 15, 2014.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
DOW CHEMICAL CO /DE/
Report date August 31, 2017 · Filed September 05, 2017
Section 16 reporting ended · disclosed 2017-09-05. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| CommonSEC Table I · non-derivative | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 1
1 source rowRow 1 · 2017-08-31 · Disposition to issuer · Disposed 450,051.7416 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2: Includes 16,940 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 18,210 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 14,100 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan | 0 |
Reported balance
After 2017-08-31 transaction · row 2
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 2 · 2017-08-31 · Disposition to issuer · Disposed 998.1368 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| CommonSEC Table I · non-derivative | IndirectBy 401(k) Plan ESOP | 0 |
Reported balance
After 2017-08-31 transaction · row 3
Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source rowRow 3 · 2017-08-31 · Disposition to issuer · Disposed 3,910.5892 · Balance 0 F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. |
| Deferred StockSEC Table II · derivative / convertible security | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · 2017-08-31 · Disposition to issuer · Disposed 163 · Balance 0 F3: There is no conversion price for these deferred shares. F4: Includes 108 deferred shares granted March 1, 2000 and 55 deferred shares granted February 23, 2001. F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F5: These deferred shares will be delivered in five annual installments beginning on January 31 following retirement. As a result of the Merger and pursuant to the Merger Agreement, these deferred shares were assumed by DowDuPont and will be delivered as DowDuPont Common Stock according to the same terms. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $34.00 · Expires 2022-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 5
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 5 · 2017-08-31 · Disposition to issuer · Disposed 49,044 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $61.19 · Expires 2027-02-10 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 6
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 6 · 2017-08-31 · Disposition to issuer · Disposed 71,680 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F8: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.01 · Expires 2026-02-12 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 7
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 7 · 2017-08-31 · Disposition to issuer · Disposed 91,790 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F9: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $49.44 · Expires 2025-02-13 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 8
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 8 · 2017-08-31 · Disposition to issuer · Disposed 86,570 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F10: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $46.71 · Expires 2024-02-14 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 9
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 9 · 2017-08-31 · Disposition to issuer · Disposed 87,470 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: This option was fully vested and exercisable at the time of the Merger. |
| Non-Qualified Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $32.16 · Expires 2023-02-15 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 10
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 10 · 2017-08-31 · Disposition to issuer · Disposed 201,290 · Balance 0 F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6: This option was fully vested and exercisable at the time of the Merger. |
| Phantom Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00 | Direct | 0 |
Reported balance
After 2017-08-31 transaction · row 11
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 11 · 2017-08-31 · Disposition to issuer · Disposed 1,743.783 · Balance 0 F11: There is no conversion price for these phantom stock units. F13: Each phantom stock unit was the economic equivalent of one share of Common Stock of the Issuer. As a result of the Merger, the phantom stock units in respect of deferrals and associated earnings were automatically converted to the economic equivalent of one share of DowDuPont Common Stock. F12: The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms. |
Filing footnotes · ownership attribution and instrument terms
F1: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18.
F2: Includes 16,940 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 18,210 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 14,100 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment.
F3: There is no conversion price for these deferred shares.
F4: Includes 108 deferred shares granted March 1, 2000 and 55 deferred shares granted February 23, 2001.
F5: These deferred shares will be delivered in five annual installments beginning on January 31 following retirement. As a result of the Merger and pursuant to the Merger Agreement, these deferred shares were assumed by DowDuPont and will be delivered as DowDuPont Common Stock according to the same terms.
F6: This option was fully vested and exercisable at the time of the Merger.
F7: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option.
F8: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms.
F9: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019.
F10: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018.
F11: There is no conversion price for these phantom stock units.
F12: The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms.
F13: Each phantom stock unit was the economic equivalent of one share of Common Stock of the Issuer. As a result of the Merger, the phantom stock units in respect of deferrals and associated earnings were automatically converted to the economic equivalent of one share of DowDuPont Common Stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 27, 2018 Filed Aug 30, 2018 01:21 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 100,645 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-18-012968 · doc4.xml · derivative · entry 5 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 100,645 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| August 27, 2018 Filed Aug 30, 2018 01:21 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 100,645 | $70.75 | $7,120,331.82 |
DisclosureSEC source: 0001225208-18-012968 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $70.69 to $70.86. Read SEC document |
| August 27, 2018 Filed Aug 30, 2018 01:21 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 100,645 | $32.16 | $3,236,743.20 |
DisclosureSEC source: 0001225208-18-012968 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 407,493.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 9,610 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · derivative · entry 8 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,645 Underlying: Common Stock · 9,610 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 10,231 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · derivative · entry 7 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 10,231 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F2 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 10,231 | $68.40 | $699,800.40 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 9,610 | $68.40 | $657,324.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,079.7416 Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 9,610 | $32.16 | $309,057.60 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 326,689.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 05, 2018 Filed Jun 7, 2018 21:17 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 10,231 | $34.00 | $347,854.00 |
DisclosureSEC source: 0001225208-18-010346 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 317,079.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 91,035 | $0.00 Strike: $32.16 | $0.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · derivative · entry 8 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 110,255 Underlying: Common Stock · 91,035 shares Expires 2023-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F6 · derivative.exercise_date: The options vested in three annual installments beginning on February 15, 2014. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionNon-Qualified Stock Option (Right to Buy) · Derivative | 38,813 | $0.00 Strike: $34.00 | $0.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · derivative · entry 7 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,231 Underlying: Common Stock · 38,813 shares Expires 2022-02-10 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · security: Granted under The Dow Chemical Company Amended and Restated 1988 Award and Option Plan. The Plan provides for tax withholding rights. F5 · derivative.exercise_date: The options vested in three annual installments beginning on February 10, 2013. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 91,035 | $68.41 | $6,227,613.32 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F3 · price: The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.72. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 38,813 | $68.43 | $2,656,012.40 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,883.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $68.30 to $68.66. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 38,813 | $34.00 | $1,319,642.00 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 436,696.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 22, 2018 Filed May 24, 2018 18:56 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Exercise / conversionCommon Stock | 91,035 | $32.16 | $2,927,685.60 |
DisclosureSEC source: 0001225208-18-009816 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 397,883.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 23, 2018 Filed Feb 27, 2018 22:04 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 69,400 | $72.66 | $5,042,853.84 |
DisclosureSEC source: 0001225208-18-004401 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 306,848.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $72.49 to $72.96. Read SEC document |
| February 20, 2018 Filed Feb 22, 2018 22:18 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Disposition to issuerCommon Stock | 45,445 | $71.62 | $3,254,770.90 |
DisclosureSEC source: 0001225208-18-003807 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 376,248.7416 F1 · kind: The deferred shares of Common stock converted from performance based awards to be delivered on or about February 13, 2018, were settled in cash on February 20, 2018 at the election of the Reporting Person. F2 · balance_after: Amount includes 2,481 shares of Common Stock previously acquired under The Dow Chemical Company Employee Stock Purchase Plan which were inadvertently omitted from the Reporting Person's Form 3. Read SEC document |
| February 15, 2018 Filed Feb 21, 2018 00:41 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | GrantNon-Qualified Stock Option (Right to Buy) · Derivative | 223,157 | $0.00 Strike: $71.85 | $0.00 |
DisclosureSEC source: 0001225208-18-003482 · doc4.xml · derivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 223,157 Underlying: Common Stock · 223,157 shares Expires 2028-02-15 F3 · security: Granted under The Dow Chemical Company Amended and Restated 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F4 · derivative.exercise_date: This option will vest in three equal installments beginning on February 15, 2019. Option shares may be used to satisfy withholding taxes. Read SEC document |
| February 13, 2018 Filed Feb 21, 2018 00:41 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | Tax withholdingCommon Stock | 5,331 | $70.75 | $377,168.25 |
DisclosureSEC source: 0001225208-18-003482 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 419,212.7416 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Shares used to satisfy withholding taxes on delivery of deferred stock granted February 13, 2015 as previously reported. Read SEC document |
| December 13, 2017 Filed Dec 13, 2017 21:30 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | GiftCommon Stock | 1,847 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-018598 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 424,543.7416 Read SEC document |
| November 21, 2017 Filed Nov 24, 2017 13:30 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 40,528 | $71.51 | $2,898,027.59 |
DisclosureSEC source: 0001225208-17-017657 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 426,390.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $71.49 to $71.545. Read SEC document |
| November 16, 2017 Filed Nov 20, 2017 21:28 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 23,778 | $70.70 | $1,681,213.98 |
DisclosureSEC source: 0001225208-17-017520 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 466,918.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $70.66 to $70.725. Read SEC document |
| November 07, 2017 Filed Nov 9, 2017 21:49 UTC | DuPont de Nemours, Inc. DWDP · Entity 3297 | SaleCommon Stock | 78,895 | $71.00 | $5,601,545.00 |
DisclosureSEC source: 0001225208-17-017151 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Special Counsellor · General Counsel-MatCo 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,696.7416 F1 · shares: The number of shares are aggregated for sales occurring within a $1.00 price range on the same date. Reporting Person agrees to provide upon request by the Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price. F2 · price: The price represents the weighted average sale price. All sales occurred at a range of $70.89 to $71.13. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerPhantom Stock Units · Derivative | 1,743.783 | Not disclosed Strike: $0.00 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 11 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 1,743.783 shares Expires not disclosed F11 · derivative.exercise_price: There is no conversion price for these phantom stock units. F13 · price: Each phantom stock unit was the economic equivalent of one share of Common Stock of the Issuer. As a result of the Merger, the phantom stock units in respect of deferrals and associated earnings were automatically converted to the economic equivalent of one share of DowDuPont Common Stock. F12 · derivative.exercise_date: The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms. F12 · derivative.expiration_date: The phantom stock units were to be delivered entirely in cash in ten annual installments beginning in January following retirement. As a result of the Merger, these phantom stock units were assumed by DowDuPont and will be delivered according to the same terms. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 201,290 | Not disclosed Strike: $32.16 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 10 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 201,290 shares Expires 2023-02-15 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 87,470 | Not disclosed Strike: $46.71 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 9 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 87,470 shares Expires 2024-02-14 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 86,570 | Not disclosed Strike: $49.44 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 8 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 86,570 shares Expires 2025-02-13 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F10 · derivative.exercise_date: Two-thirds of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $49.44 per share, with the remaining one-third of the option vesting on February 13, 2018. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 91,790 | Not disclosed Strike: $46.01 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 7 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 91,790 shares Expires 2026-02-12 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F9 · derivative.exercise_date: One-third of this option was vested at the time of the Merger. The option was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont common stock for $46.01 per share, with the remaining two-thirds of the option vesting in two equal installments on February 12, 2018 and February 12, 2019. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 71,680 | Not disclosed Strike: $61.19 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 6 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 71,680 shares Expires 2027-02-10 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F8 · derivative.exercise_date: This option, which would have vested in three equal installments beginning on February 10, 2018, was assumed by DowDuPont in the Merger and converted into an option to purchase an equal number of shares of DowDuPont Common Stock for $61.19 per share on the same vesting terms. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerNon-Qualified Stock Option (right to buy) · Derivative | 49,044 | Not disclosed Strike: $34.00 | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 5 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 49,044 shares Expires 2022-02-10 F7 · price: In accordance with the terms of the Merger Agreement, each stock option of the Issuer outstanding immediately prior to the effective time of the Merger (whether vested or unvested) was automatically converted into an option to purchase shares of DowDuPont common stock equal to the total number of shares of Common Stock subject to such option immediately prior to the closing of the Merger and at a per-share exercise price equal to the per-share exercise price of the Issuer's option. F6 · derivative.exercise_date: This option was fully vested and exercisable at the time of the Merger. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerDeferred Stock · Derivative | 163 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · derivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 163 shares Expires not disclosed F3 · derivative.exercise_price: There is no conversion price for these deferred shares. F4 · shares: Includes 108 deferred shares granted March 1, 2000 and 55 deferred shares granted February 23, 2001. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F5 · derivative.exercise_date: These deferred shares will be delivered in five annual installments beginning on January 31 following retirement. As a result of the Merger and pursuant to the Merger Agreement, these deferred shares were assumed by DowDuPont and will be delivered as DowDuPont Common Stock according to the same terms. F5 · derivative.expiration_date: These deferred shares will be delivered in five annual installments beginning on January 31 following retirement. As a result of the Merger and pursuant to the Merger Agreement, these deferred shares were assumed by DowDuPont and will be delivered as DowDuPont Common Stock according to the same terms. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 3,910.5892 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan ESOP Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 998.1368 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Indirect · By 401(k) Plan Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| August 31, 2017 Filed Sep 5, 2017 21:17 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Disposition to issuerCommon | 450,051.7416 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-014607 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 F1 · kind: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. F2 · shares: Includes 16,940 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 13, 2018 as DowDuPont Common Stock, 18,210 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 12, 2019 as DowDuPont Common Stock and 14,100 deferred shares that, as a result of the Merger and pursuant to the Merger Agreement, were assumed by DowDuPont and will be delivered on or about February 10, 2020 as DowDuPont Common Stock, in each case, contingent upon continued employment. F1 · price: Reflects disposition in connection with the consummation of the transactions contemplated by the Agreement and Plan of Merger, dated as of December 11, 2015, as amended on March 31, 2017 (the "Merger Agreement"), by and among the Issuer, E. I. du Pont de Nemours and Company, DowDuPont Inc. (f/k/a Diamond-Orion HoldCo, Inc., "DowDuPont"), Diamond Merger Sub, Inc. and Orion Merger Sub, Inc, pursuant to which Merger Sub merged with and into the Issuer (the "Merger"), with the Issuer surviving as a wholly-owned subsidiary of DowDuPont. In the Merger, each share of Issuer Common Stock, par value $2.50 per share, was exchanged for one share of common stock, par value $0.01 per share, of DowDuPont ("DowDuPont Common Stock"). The closing price of a share of Common Stock on August 31, 2017 (the last trading day prior to the effectiveness of the Merger) was $66.65, and the closing price of a share of DowDuPont common stock on September 1, 2017 (the effective date of the Merger) was $67.18. Read SEC document |
| February 14, 2017 Filed Feb 16, 2017 21:18 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 5,965 | $61.72 | $368,159.80 |
DisclosureSEC source: 0001225208-17-003573 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 448,001.7416 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. F2 · shares: Stock withheld on the delivery date to cover taxes for deferred stock granted on February 14, 2014, as previously reported. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantNon-Qualified Stock Option (right to buy) · Derivative | 71,680 | $0.00 Strike: $61.19 | $0.00 |
DisclosureSEC source: 0001225208-17-003209 · doc4.xml · derivative · entry 4 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,680 Underlying: Common · 71,680 shares Expires 2027-02-10 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 10, 2018. Read SEC document |
| February 10, 2017 Filed Feb 14, 2017 21:14 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | GrantCommon | 14,100 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-17-003209 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 453,966.7416 F1 · security: Granted under The Dow Chemical Company 2012 Stock Incentive Plan. The Plan provides for tax withholding rights. F2 · shares: Deferred shares to be delivered in one installment on or about February 10, 2020 contingent upon continuation of employment. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 70,000 | $0.00 Strike: $43.59 | $0.00 |
DisclosureSEC source: 0001225208-17-002232 · doc4.xml · derivative · entry 6 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common · 70,000 shares Expires 2017-02-16 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · security: Granted under The Dow Chemical Company 1988 Award and Option Plan. The Plan provides for tax withholding rights. F3 · derivative.exercise_date: The options vest in three equal annual installments beginning on February 16, 2008. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 50,548 | $60.37 | $3,051,330.02 |
DisclosureSEC source: 0001225208-17-002232 · doc4.xml · nonDerivative · entry 3 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 439,866.7416 Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Tax withholdingCommon | 6,622 | $60.37 | $399,737.03 |
DisclosureSEC source: 0001225208-17-002232 · doc4.xml · nonDerivative · entry 2 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 490,414.7416 F1 · kind: Shares withheld pursuant to tax withholding rights under award and option plans in a transaction exempt under Rule 16b-3. Read SEC document |
| January 31, 2017 Filed Feb 2, 2017 20:38 UTC | DOW CHEMICAL CO /DE/ DOW · Entity 97744 | Exercise / conversionCommon | 70,000 | $43.59 | $3,051,300.00 |
DisclosureSEC source: 0001225208-17-002232 · doc4.xml · nonDerivative · entry 1 KALIL CHARLES J · CIK 0001308007 · Exec VP and General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 497,036.7416 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.